In malignant mesothelioma, NF2/merlin inactivation is observed in approximately 40% of cases, indicating its critical role in cancer development and progression, which is associated with the activation of the Hippo and mTOR signaling pathways involved in cancer progression.38 This evidence concerns the gene NF2 and cancer.